Personalized medicine: The promise, the reality
The Journal of Family Practice. 2007 August;56(8):621-626
August 1, 2007|Family Medicine
Author and Disclosure Information
Genetic testing can tell us how a patient will metabolize warfarin, but no one can tell us how to adjust our dosing.
Outcomes data will undoubtedly be key. With it, pharmacogenetic testing has the potential to grow by leaps and bounds—perhaps even becoming a standard of care in guiding pharmacological therapy. Without it, such testing will remain a promising, but as yet unrealized advance in personalized medicine.
Correspondence
Doug Campos-Outcalt, MD, MPA, 550 E. Van Buren, Phoenix, AZ 85004; dougco@u.arizona.edu.
